Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.92 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.92 |
| ▸ | PAM | P19021 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.32 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL25317376 | 1.00 | CYP2D6 (0.92) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL28168136 | 0.96 | CYP2D6 (1.00) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL190067 | 0.96 | CYP2D6 (1.00) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL3134391 | 0.96 | CYP2D6 (1.00) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL213024 | 0.96 | CYP2D6 (1.00) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| Hydrochloric Acid SCHEMBL10880042 | 0.92 | CYP2D6 (0.92) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL11135300 | 0.86 | ALDH1A1 (0.80) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL11135303 | 0.86 | ALDH1A1 (0.80) | CYP2D6ALDH1A1ALOX15PAMLMNA | |
| SCHEMBL8735867 | 0.83 | — | — | |
| SCHEMBL1246559 | 0.83 | ALDH1A1 (0.75) | CYP2D6ALDH1A1ALOX15PAMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12486283-B2 | Crystalline salt of eribulin | YONSUNG FINE CHEMICAL CO., LTD. (KR) | 2025-12-02 | — | — | US | disclosed |
| US-20230234961-A1 | CRYSTALLINE SALT OF ERIBULIN | YONSUNG FINE CHEMICAL CO., LTD. (KR) | 2023-07-27 | — | — | US | disclosed |
| EP-4151639-A1 | CRYSTALLINE SALT OF ERIBULIN | Yonsung Fine Chemical Co., Ltd. (KR) | 2023-03-22 | — | — | EP | disclosed |
| CN-115551866-A | Crystalline salts of eribulin | 研成精密化学株式会社 | 2022-12-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234961-A1 | CRYSTALLINE SALT OF ERIBULIN | ERLIN1, ERLIN2, ERGIC1 | CYP2D6 1608/4885ALDH1A1 3081/4885ALOX15 3251/4885 |
| US-12486283-B2 | Crystalline salt of eribulin | ERLIN1, ERLIN2, ERGIC1 | CYP2D6 1608/4885ALDH1A1 3081/4885ALOX15 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.